Skip to content
aiqbench takeMachine Learning

aiqbench analysis

This study benchmarks deep learning models against clinical standards in detecting age-related macular degeneration progression using optical coherence tomography data from the MARIO challenge. The results demonstrate that AI algorithms can match physician-level accuracy for classifying disease evolution, establishing a new baseline for automated ophthalmic monitoring systems. While the application is medical imaging, the core contribution lies in advancing machine learning methodologies for longitudinal prediction and handling multi-modal clinical datasets.
Source coveringarXiv
What this isA model's reading of the article and related coverage, written for aiqbench. Not the publisher's words.

Deep Learning for Retinal Degeneration Assessment: A Comprehensive Analysis of the MARIO Challenge

arXiv3 min read

arXiv:2506.02976v4 Announce Type: replace-cross Abstract: The MARIO challenge, held at MICCAI 2024, focused on advancing the automated detection and monitoring of age-related macular degeneration (AMD) through the analysis of optical coherence tomography (OCT) images. Designed to evaluate algorithmic performance in detecting neovascular activity changes within AMD, the challenge incorporated unique multi-modal datasets. The primary dataset, sourced from Brest, France, was used by participating teams to train and test their models. The final ranking was determined based on performance on this dataset. An auxiliary dataset from Algeria was used post-challenge to evaluate population and device shifts from submitted solutions. Two tasks were involved in the MARIO challenge. The first one was the classification of evolution between two consecutive 2D OCT B-scans. The second one was the prediction of future AMD evolution over three months for patients undergoing anti-vascular endothelial growth factor (VEGF) therapy. Thirty-five teams participated, with the top 12 finalists presenting their methods. This paper outlines the challenge's structure, tasks, data characteristics, and winning methodologies, setting a benchmark for AMD monitoring using OCT, infrared imaging, and clinical data (such as the number of visits, age, gender, etc.). The results of this challenge indicate that artificial intelligence (AI) performs as well as a physician in measuring AMD progression (Task 1) but is not yet able of predicting future evolution (Task 2).

Authors:Rachid Zeghlache, Ikram Brahim, Pierre-Henri Conze, Mathieu Lamard, Mohammed El Amine Lazouni, Zineb Aziza Elaouaber, Leila Ryma Lazouni, Christopher Nielsen, Ahmad O. Ahsan, Matthias Wilms, Nils D. Forkert, Lovre Antonio Budimir, Ivana Matovinović, Donik Vršnak, Sven Lončarić, Philippe Zhang, Weili Jiang, Yihao Li, Yiding Hao, Markus Frohmann, Patrick Binder, Marcel Huber, Taha Emre, Teresa Finisterra Araújo, Marzieh Oghbaie, Hrvoje Bogunović, Amerens A. Bekkers, Nina M. van Liebergen, Hugo J. Kuijf, Abdul Qayyum, Moona Mazher, Steven A. Niederer, Alberto J. Beltrán-Carrero, Juan J. Gómez-Valverde, Javier Torresano-Rodríquez, Álvaro Caballero-Sastre, María J. Ledesma Carbayo, Yosuke Yamagishi, Yi Ding, Robin Peretzke, Alexandra Ertl, Maximilian Fischer, Jessica Kächele, Sofiane Zehar, Karim Boukli Hacene, Thomas Monfort, Béatrice Cochener, Mostafa El Habib Daho, Anas-Alexis Benyoussef, Gwenolé Quellec

Abstract:The MARIO challenge, held at MICCAI 2024, focused on advancing the automated detection and monitoring of age-related macular degeneration (AMD) through the analysis of optical coherence tomography (OCT) images. Designed to evaluate algorithmic performance in detecting neovascular activity changes within AMD, the challenge incorporated unique multi-modal datasets. The primary dataset, sourced from Brest, France, was used by participating teams to train and test their models. The final ranking was determined based on performance on this dataset. An auxiliary dataset from Algeria was used post-challenge to evaluate population and device shifts from submitted solutions. Two tasks were involved in the MARIO challenge. The first one was the classification of evolution between two consecutive 2D OCT B-scans. The second one was the prediction of future AMD evolution over three months for patients undergoing anti-vascular endothelial growth factor (VEGF) therapy. Thirty-five teams participated, with the top 12 finalists presenting their methods. This paper outlines the challenge's structure, tasks, data characteristics, and winning methodologies, setting a benchmark for AMD monitoring using OCT, infrared imaging, and clinical data (such as the number of visits, age, gender, etc.). The results of this challenge indicate that artificial intelligence (AI) performs as well as a physician in measuring AMD progression (Task 1) but is not yet able of predicting future evolution (Task 2).

Computer Vision and Pattern Recognition (cs.CV); Artificial Intelligence (cs.AI)

arXiv:2506.02976 [cs.CV]

(or arXiv:2506.02976v4 [cs.CV] for this version)

Full text under the publisher's open licence · 352 words

Related coverage